Eileen Shore and Frederick Kaplan of the Perelman School of Medicine and Masahiro Iwamoto of the Children’s Hospital of Philadelphia are featured for their collaborative research that found a drug candidate that may treat a rare disabling bone disease.

April 18, 2016 ・ From Philly.com